Portfolio

Portfolio

LongRiver team has managed over USD 1 billion in assets, with investments in more than 80 companies worldwide(includes pre-fund track record), 20+ of which have successfully completed IPOs (including listings on the Hong Kong Stock Exchange, NYSE/Nasdaq, and the A-share market).

Allorion
Belenos
CamGene
Huiyueyan
Maxvax
Oculgen
Ouro Medicines
M&A
Peptidstar
更多
加载中